Da Cheng Qi Decoction attenuates LPS-induced intestinal injury in rats in association with modulation of CHI3L1-associated inflammatory signaling and metabolic alterations
Digestion · 2026-11-05
DOI: 10.1159/dig/acmag036 ↗Abstract
Abstract Introduction: Sepsis-induced intestinal injury (SII) is a life-threatening gastrointestinal complication characterized by intestinal barrier dysfunction, metabolic disturbance, and excessive inflammation, while effective targeted interventions remain limited. Da Cheng Qi Decoction (DCQD), a classical East Asian traditional medicine formula, has shown protective effects against sepsis-associated intestinal dysfunction; however, the molecular networks underlying its effects remain incompletely understood. Here, we integrated metabolomic and proteomic analyses with experimental validation to investigate the potential regulatory mechanisms associated with DCQD-mediated protection against SII. Methods: A rat SII model was established in male Sprague-Dawley rats by LPS induction, and an in vitro intestinal injury model was generated using LPS-stimulated human colonic epithelial cells (CCD841). Integrated metabolomic and proteomic profiling of ileal tissues, together with in vivo and in vitro validation experiments, was performed to characterize DCQD-associated metabolic and inflammatory alterations and identify potential molecular networks involved in its protective effects. Results: Multi-omics identified 11 altered metabolites and 22 differentially expressed proteins after DCQD treatment, with CHI3L1 prioritized as a candidate molecule through exploratory multi-omics analysis and associated with bile acid and glucose metabolism (P < 0.05). In vitro, CHI3L1 silencing or DCQD-containing serum alleviated LPS-induced cellular injury (P < 0.01), and combined intervention showed enhanced protective effects on CCD841 cells, including improved cell viability, reduced apoptosis, and decreased secretion of IL-6, IL-1β, and TNF-α (all P < 0.05). In vivo, DCQD administration or CHI3L1 silencing ameliorated ileal histopathological injury, reduced inflammatory cytokine levels, improved intestinal barrier-related dysfunction reflected by citrulline and D-lactate levels, and decreased JAK2/STAT3 phosphorylation. These findings suggest that modulation of CHI3L1-associated inflammatory signaling may contribute to the protective effects of DCQD against SII. Conclusions: The present findings suggest that DCQD attenuates SII and is associated with modulation of metabolic alterations and CHI3L1-associated inflammatory signaling responses. CHI3L1 may represent a potential molecular mediator involved in SII progression and DCQD-mediated protection. These exploratory findings provide preliminary insights into the molecular networks associated with the protective effects of DCQD against septic intestinal injury.
EUVIMED